Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › ADVENZYMES

ADVENZYMES

Advanced Enzyme Technologies Limited
Micro-capChemicals ↗

What the six lenses say about ADVENZYMES — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹297.9
2026-09-08
VWAP · 1Y anchor
₹331
-10.0% from VWAP
P/E · TTM
19.8×
TTM EPS ₹15.1
52-week range
31%
position low→high
RSI(14)
44
momentum

Own sector index

Chemicals ↗
Neutral

1M

-2.7%

3M

+4.7%

1Y

—

Breadth >EMA21

40%

How ADVENZYMES’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
3.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD38›

The actual numbers

Price vs VWAP (1y)-10.0%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-6.7%
Price vs 50-EMA-4.6%
RSI(14)44
RS vs Nifty 500 · 3M-24.4%
RS vs sector · 3M-24.6%
52-week range31%
Volume vs 30d avg0.59×
Volume vs 60d avg0.57×
ATR(14) · volatility9.5
Bollinger width · vol contraction0.050
FundamentalD971›

The actual numbers

Return on equity (ROE)10.6%
Operating margin31.8%
Net margin23.2%
Revenue growth · YoY+17.2%
EPS growth · YoY+28.7%
Debt / equity0.02×

Full 8-quarter history in the financials table below.

ValuationD859›

The actual numbers

P/E (TTM)19.8×
TTM EPS₹15.1
52-week range31%
CatalystD847›

The actual numbers

Earnings & momentum39
Capital actions57
Governance58

Every filing in the corporate-announcements panel below.

FlowD442›

The actual numbers

Promoter holding43.3%
Delivery · 30d avg57.9%
Up/down-day asymmetry-4.4pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D3 + D4 ) ÷ 2 = 3.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
11
Conviction score 11/100 · avg-decile strength 3.5/10
Conviction score11/100›
TechnicalD3›
FundamentalD9›
ValuationD8›
CatalystD8›
FlowD4›

Policy

Government policy · Chemicals

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Watch· MEDIUM impact

China+1 Manufacturing Shift

Supply-chain diversification away from China benefiting Indian chemical and component manufacturers

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+2.1pp
+2.5pp
-6.2pp
-22.8pp
+2.9pp
-9.9pp
Nifty 500
Broad-market baseline
+2.0pp
+2.5pp
-7.3pp
-24.4pp
-2.8pp
-15.1pp
Sector
Own-sector index
—
—
-7.0pp
-24.6pp
-9.0pp
—

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

ADVENZYMES daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
297.85+4.65

Relative strength

RS vs baseline · rebased to 100

ADVENZYMES ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
67.24+1.33

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)155146169167186185172203
↳ change QoQ—-5.5%+15.8%-1.2%+11.4%-0.5%-7.0%+18.0%
EBITDA (₹cr)5852634656604963
EBITDA margin37.6%35.6%37.2%27.5%30.1%32.4%28.5%31.0%
PAT (₹cr)3533392740454345
↳ change QoQ—-4.5%+16.4%-30.5%+48.1%+12.5%-4.4%+4.7%
Net margin22.6%22.9%23.0%16.2%21.5%24.3%25.0%22.2%
EPS (₹)3.052.943.362.373.573.873.803.84
D/E0.000.00——————
YoY growth · Mar '26Revenue +21.6% YoYPAT +66.7% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 8 Sep '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 11 Aug '26
    HIGHcapital
    Buyback
    ›

    A share buyback — the company is returning cash and signalling the board sees the stock as undervalued.

    View original filing on NSE ↗
  • 11 Aug '26
    HIGHcapital
    Public Announcement - Buyback of Shares
    ›

    A share buyback — the company is returning cash and signalling the board sees the stock as undervalued.

    View original filing on NSE ↗
  • 8 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 Aug '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 4 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Chemicals